Pharma stocks tumble amid drug quality concerns
Pharma stocks tumble amid drug quality concerns

Pharma stocks tumble amid drug quality concerns

Geyatee Deshpande Article rating: 3.3

As the market reversed its trend to downside, pharma and auto stocks led the losses in Friday’s trading session. While auto stocks fell amid concerns about sales growth, the pharma stocks had to face the brunt of drug quality, triggered by suspension of ranitidine hydrochloric drug.

Rupee continues to strengthen for second-straight session
Rupee continues to strengthen for second-straight session

Rupee continues to strengthen for second-straight session

Pratik Shastri Article rating: 5.0

The currency appreciation is positive for the overall sentiment of the markets. Strong currency and decline in crude oil prices will be key drivers for the markets going ahead.

Strides Pharma gets approval for Solifenacin SuccinateTablets
Strides Pharma gets approval for Solifenacin SuccinateTablets

Strides Pharma gets approval for Solifenacin SuccinateTablets

Pritam Bhawar Article rating: 3.5

The company informed on Friday that Stride Pharma Global Pte Limited, Singapore, has received approval from the United States Food and Drug Administration (USFDA) for manufacturing Solifenacin SuccinateTablets, 5 mg and 10 mg.

iGTB of Intellect Design organises Sibos networking cruise
iGTB of Intellect Design organises Sibos networking cruise

iGTB of Intellect Design organises Sibos networking cruise

Pritam Bhawar Article rating: 5.0

Intellect Global Transaction Banking (iGTB), the transaction banking and tech specialist from Intellect Design Arena Limited, in partnership with Fintech Power 50 on Tuesday organised a SIBOS networking cruise that brings together major banks, insurers and market infrastructure players.

RSS
First30273028302930303032303430353036Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR